Cohort study reveals high disease burden and medical costs in chronic hepatitis B and C patients in South Korea, suggesting urgent screening measures.
CHB/CHC is burdensome in its disease progression risk and medical costs compared to monoinfection. An effective screening strategy for early management of CHB/CHC is warranted for public health in South Korea.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: